|
²¹²Pb-DOTAM-GRPR1 Clinical Trials
1 actively recruiting trial across 1 location
Chicago, Illinois1 trial
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Northwestern University Robert H Lurie Medical Research
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.